The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

Wen Zhang; Yan Zhao; Fengchun Zhang; Qian Wang; Taisheng Li; Zhengyin Liu; Jinglan Wang; Yan Qin; Xuan Zhang; Xiaowei Yan; Xiaofeng Zeng; Shuyang Zhang

doi:10.1016/j.clim.2020.108393

Keywords

MedicinePandemicCoronavirus disease 2019 (COVID-19)OutbreakDiseaseCoronavirus2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Intensive care medicineImmunologyImmune systemCase fatality rateInternal medicineVirologyEpidemiologyInfectious disease (medical specialty)

Affiliated Institutions

Related Publications

Drug treatment options for the 2019-new coronavirus (2019-nCoV)

Hongzhou Lu

As of January 22, 2020, a total of 571 cases of the 2019-new coronavirus (2019-nCoV) have been reported in 25 provinces (districts and cities) in China. At present, there is no ...

2020 BioScience Trends 1183 citations

The Coronavirus Disease 2019 (COVID-19) Pandemic

Saira Baloch , Mohsin Ali Baloch , Tianli Zheng +1 more

The present study provides an overview of the coronavirus disease 2019 (COVID-19) outbreak which has rapidly extended globally within a short period. COVID-19 is a highly infect...

2020 The Tohoku Journal of Experimental Me... 1483 citations

Discovering drugs to treat coronavirus disease 2019 (COVID-19)

Liying Dong , Shasha Hu , Jianjun Gao

The SARS-CoV-2 virus emerged in December 2019 and then spread rapidly worldwide, particularly to China, Japan, and South Korea. Scientists are endeavoring to find antivirals spe...

2020 Drug Discoveries & Therapeutics 1438 citations

Review of Current Vaccine Development Strategies to Prevent Coronavirus Disease 2019 (COVID-19)

Bindu Bennet , Jayanthi Wolf , Rodrigo Laureano +1 more

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) outbreak that started in Wuhan, China, in 2019 resulted in a pandemic not seen for a century, and there is an ur...

2020 Toxicologic Pathology 47 citations

Coronavirus Disease 2019 (COVID-19): A Perspective from China

Ziyue Zu , Meng Jiang , Peng Xu +4 more

In December 2019, an outbreak of severe acute respiratory syndrome coronavirus 2 infection occurred in Wuhan, Hubei Province, China, and spread across China and beyond. On Febru...

2020 Radiology 2129 citations

Publication Info

Year: 2020
Type: review
Volume: 214
Pages: 108393-108393
Citations: 1292
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

1292

OpenAlex

Cite This

APA Style

                            
                                    Wen Zhang, 
                                
                                    Yan Zhao, 
                                
                                    Fengchun Zhang
                                
                                et al.
                            
                            (2020). 
                            The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China. 
                            Clinical Immunology
                            , 214
                            
                            , 108393-108393.
                            https://doi.org/10.1016/j.clim.2020.108393

Identifiers

DOI: 10.1016/j.clim.2020.108393